METFORMIN AND ASPIRIN: NEW HOPE

Metformin:

It is a popular diabetes medication but two new clinical studies were  presented at the annual meeting of the American Association for Cancer Research. It was found that metformin may slow the rate of prostate cancer growth in certain patients, and in prolonging life for early-stage pancreatic cancer patients. The drug might have an effect against liver or oral tumors, as well as certain forms of melanoma and this study was done either in the lab or in animals. Metformin is also found to be effective against colon and breast cancer. Continue Reading

Advertisements